Visiting Professors

ResearchToPractice.com/VPB210 – A 51-yo woman with a 3-cm, Grade II, strongly ER/PR+, HER2- IDC has 17/18 positive axillary nodes and 4 satellite breast nodules. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB210 – A 65-yo woman has bone and hepatic metastases after 4 years of treatment with adjuvant letrozole for a 1.2-cm, ER+, HER2-, node- IDC. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB110 – A 67yo has a 1.3-cm, Grade II, strongly ER+, HER2- IDC with lymphovascular invasion and 1 lymph node with a 2-mm micromet and an Oncotype DX RS of 24. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB110 – A 52yo premenopausal woman develops erythematous, ulcerated, ER/PR+, HER2+ BC while receiving AC>TH and tamoxifen for contralateral BC. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB110 – A 77yo woman presents with a 10-cm, Grade III, weakly ER/PR+, HER2-equivocal, node+ IDC and questionable liver and bone mets. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB110 – A 50yo premenopausal woman has locally advanced ER+, HER2- IDC and widespread mets to the bone, lung and brain. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB110 – A 54yo woman with bipolar disorder is diagnosed with a 1.6-cm, Grade III, strongly ER+, weakly PR+, HER2-, node- IDC and an Oncotype DX RS of 32. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB110 – A 54yo woman develops painful, biopsyconfirmed triple-negative sternal mets 7 years after completion of adjuvant dose-dense AC paclitaxel. Interview conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 1: A 41-year-old woman with a metastatic ER-positive, HER2-negative invasive ductal carcinoma (IDC) after being treated two years ago with neoadjuvant AC followed by T, mastectomy, radiation therapy and tamoxifen. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 2: A 59-year-old woman with bone metastases two years after the diagnosis of a Grade II, node-positive, ER-positive, PR-positive, HER2-positive IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 3: A 72-year-old woman with cancer recurrence nine years after diagnosis of a 1-cm, poorly differentiated, node-positive, ER-positive, PR-negative, HER2-negative IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 4: A 51-year-old postmenopausal woman diagnosed five years ago with 4-cm and 1-cm node-positive, ER-positive, HER2-negative IDCs. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 5: A woman diagnosed nine years ago at the age of 42 with a 9-cm, ER-positive, PR-positive, HER2-positive IDC who has received multiple lines of therapy for metastatic disease. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 6: A 51-year-old postmenopausal woman with a 1.3-cm, Grade II, node-negative, ER-positive, PR-positive, HER2-negative IDC and an Oncotype DX® Recurrence Score® of 21 (intermediate risk). Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 7: A 50-year-old woman with rising tumor markers and a PET scan-documented solitary lesion in her rib four years after being diagnosed with a T1cN2aM0, ER-positive (10 percent), HER2-negative IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 8: A 74-year-old woman with a cutaneous chest wall recurrence of metastatic ER-negative, PR-negative, HER2-positive inflammatory BC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 9: A 62-year-old woman with bilateral (10 centimeters and 15 centimeters), Grade III, node-positive, ER-positive, HER2-negative IDCs with focal lobular features and bone metastases. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 10: A 47-year-old premenopausal woman with a family history of breast and ovarian cancer who refuses hormonal therapy for a 1.9-cm, Grade III, node-positive, ER-positive, PR-positive, HER2-positive IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPB209 - Case 11: A 47-year-old woman with extensive, high-grade, multifocal ductal carcinoma in situ (DCIS), a 3-mm focus of ER-positive, PR-negative, HER2-positive IDC and an Oncotype DX Recurrence Score of 34 (high risk). Interviews conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/VPC109 - Case 1: A 61-year-old woman with an obstructing, K-ras wild-type colon cancer and three synchronous liver metastases who underwent subtotal colectomy followed by CAPOX and partial hepatectomy. Interviews conducted by Neil Love, MD. Produced by Research To Practice.